Prognostic value of the lung immune prognostic index in patients with untreated advanced renal cell carcinoma (aRCC) receiving nivolumab plus ipilimumab (N+I) or sunitinib (SUN) in the CheckMate 214 trial Meeting Abstract
| Authors: | Carril-Ajuria, L.; Motzer, R. J.; Tannir, N. M.; McDermott, D. F.; Hammers, H. J.; Plimack, E. R.; Donskov, F.; Rini, B. I.; Jiang, R.; Lee, C. W.; Desilva, H.; Albiges, L. |
| Abstract Title: | Prognostic value of the lung immune prognostic index in patients with untreated advanced renal cell carcinoma (aRCC) receiving nivolumab plus ipilimumab (N+I) or sunitinib (SUN) in the CheckMate 214 trial |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680301358 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.4538 |
| Notes: | Meeting Abstract: 4538 -- This meeting was also held virtually -- Source: Wos |
